Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Calithera Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 55 | 29 | −26 |
| SharesConverted for a 1-for-20 split | 2.10M | 1.75M | −351.2K (−16.7%) |
| Value | $18.0M | $4.44M | −$13.6M (−75.4%) |
New holders (6)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 14,503 | $36.0K | 0.00% |
| Susquehanna International Group, LLP | 10,177 | $25.0K | 0.00% |
| Tarbox Family Office, Inc. | 10,000 | $25.0K | 0.01% |
| Lindbrook Capital, LLC | 500 | $1.00K | 0.00% |
| Cordasco Financial Network | 40 | $0 | 0.00% |
| Truvestments Capital LLC | 64 | $0 | 0.00% |
Sold out (32)
Institutions that held Calithera Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.